Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KPRX stock hub

Kiora Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KPRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KPRX

In the news

Latest news · KPRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-58.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-32.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KPRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001372514
Company name	Kiora Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	49721T101
Employees	13
Employees Change	1%
Employees Change Percent	8.33
Enterprise value	$-2.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US49721T5074
Last refreshed	2026-05-10
Market cap	$10.8M
Market cap category	Nano-Cap
Price	$2.45
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	KPRX
Website	https://www.kiorapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-102.85%
FCF yield	-97.96%
P/B ratio	0.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-3.7M
Net Income	$-11.1M
Net Income Growth Years	0%
Profit Per Employee	$-850,781
ROA	-22.41
Roa5y	-22.19
ROCE	-53.76
ROE	-58.78
Roe5y	-77.98
ROIC	-32.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-58.69%
Cagr1y	-26.88%
Cagr3y	-53.79%
Cagr5y	-71.97%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$21.2M
Cash	$13.9M
Current Assets	$18.7M
Current Liabilities	$2.8M
Debt	$373,586
Debt Equity	$0.03
Equity	$13.9M
Interest Coverage	-63
Liabilities	$7.3M
Long Term Assets	$2.5M
Long Term Liabilities	$4.5M
Net Cash	$13.5M
Net Cash By Market Cap	$126
Net Cash Growth	-43.63%
Net Debt Equity	$-0.97
Tangible Book Value	$11.9M
Tangible Book Value Per Share	$2.97
WACC	2.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.68
Net Working Capital	$2.2M
Quick ratio	6.19
Working Capital	$15.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.2%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.99%
1Y total return	-26.87%
200-day SMA	2.34
3Y total return	-90.14%
50-day SMA	2.24
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.83%
All Time High	189,000.2
All Time High Change	-100%
All Time High Date	2015-07-22
All Time Low	1.77
All Time Low Change	38.81%
All Time Low Date	2025-11-25
ATR	0.16
Beta	-0.47
Beta1y	1.08
Beta2y	1.26
Ch YTD	24.37
High	2.71
High52	4.18
High52 Date	2025-06-03
High52ch	-41.39%
Low	2.4
Low52	1.77
Low52 Date	2025-11-25
Low52ch	38.81%
Ma50ch	9.52%
Premarket Change Percent	2.86
Premarket Price	$2.52
Premarket Volume	1,319
Price vs 200-day SMA	4.88%
RSI	55.58
RSI Monthly	31.23
RSI Weekly	54.2
Sharpe ratio	-0.14x
Sortino ratio	-0.15
Total Return	1.2%
Tr YTD	24.37
Tr1m	13.43%
Tr1w	0.41%
Tr3m	13.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.7
Earnings Revenue Estimate	1,500,000x
Operating Income	$-9.9M
Price target	$10
Price Target Change	$308

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,253,917%
Float Percent	96.92%
Shares Insiders	3.08%
Shares Institutions	19%
Shares Out	4,389,099
Shares Qo Q	0.11%
Shares Yo Y	-1.2%
Short Float	0.67%
Short Ratio	0.02
Short Shares	0.65

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.5M
Average Volume	61,302.55x
Bv Per Share	3.49
CAPEX	$-115,807
Ch10y	-99.99
Ch1m	13.43
Ch1w	0.41
Ch1y	-26.87
Ch3m	13.95
Ch3y	-90.14
Ch5y	-99.83
Ch6m	5.15
Change	0%
Change From Open	-9.59
Close	2.45
Days Gap	10.61
Depreciation Amortization	35,046
Dollar Volume	100,048.2
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-9.9M
EBITDA	$-9.9M
EPS	$-2.66
F Score	2
FCF	$-10.5M
FCF EV Yield	383.73x
FCF Per Share	$-2.4
Financing CF	264,813
Fiscal Year End	December
Founded	1,998
Income Tax	$-1.4M
Investing CF	17,154,845
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2024-06-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-25
Ma150	2.23
Ma150ch	10.11%
Ma20	2.44
Ma20ch	0.33%
Net CF	7,184,942
Next Earnings Date	2026-08-07
Open	2.71
Optionable	No
Position In Range	16.13
Post Close	2.45
Postmarket Change Percent	2.04
Postmarket Price	$2.5
Ppne	388,301
Pre Close	2.45
Price Date	2026-05-08
Ptbv Ratio	0.91
Relative Volume	0.67x
Share Based Comp	961,130
Tr6m	5.15%
Us State	California
Volume	40,836

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KPRX pay a dividend?

Capital-return profile for this ticker.

Performance

KPRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KPRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.0%

Float: +96.9% of shares outstanding

Insider ownership

+3.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

KPRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.6

Neutral momentum band

Price vs 200-day MA

+4.9%

50/200-day relationship not available

Beta (5Y)

-0.47

Less volatile than the market

Sharpe ratio

-0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KPRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current KPRX stock rating?

Kiora Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full KPRX analysis?

The full report lives at /stocks/KPRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for KPRX?

The latest report frames KPRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the KPRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.